They question how effective these technologies really are for managing serious conditions like cancer, diabetes, and heart disease.
Their review of 140 studies found many trials rely on tech-savvy users and self-reported data, raising doubts about wider use.
They also warn that by the time long studies finish, the technology is often already out of date.